Intervention options: Depression & Cardiovascular Disease during Covid-19 Pandemia


  • Eirini Flouda DEREE College-School of Graduate & Professional Education The American College of Greece
  • Athena Stefanatou DEREE College-School of Graduate & Professional Education The American College of Greece
  • Tinia Apergi DEREE College-School of Graduate & Professional Education The American College of Greece



Depression, cardiovascular disease, covid-19 and CVD, depression and covid-19


An attempt to review links of cardiovascular disease (CVD) and depression and present appropriate treatment methods for handling depression in the COVID-19 pandemic is made. Although depression constitutes one of the major mental health challenges that humankind must encounter in the 21st century it remains undiagnosed and untreated in CVD patients. Its great influence on the progress of CVD led to its classification as a risk factor along with dyslipidemia, arterial hypertension, diabetes, obesity, substance use, sedentary lifestyle (poor diet, stress) making imperative the need for treatment methods. As during COVID 19 pandemic we witnessed the elevation of mental distress as involving both lifestyle choices and dealing with unprecedented life situations while inducing psychological distress or exacerbating pre-existing physical and mental health problems – depression could act both as a contributor to and as the result of CVD. A 4-step intervention program is suggested.


Bucciarelli, V., Caterino, A. L., Bianco, F., Caputi, C. G., Salerni, S., Sciomer, S.,

Maffei, S., & Gallina, S.. Depression and cardiovascular disease: The deep blue sea of women’s heart. Trends in Cardiovascular Medicine. 2019 doi:10.1016/j.tcm.2019.05.001

Correll, C. U., Solmi, M., Veronese, N., Bortolato, B., Rosson, S., Santonastaso, P.,

Thapa-Chhetri, N., Fornaro, M., Gallicchio, D., Collantoni, E., Pigato, G., Favaro, A., Monaco, F., Kohler, C., Vancampfort, D., Ward, B.P., Gaughran, F., Carvalho, A.F., & Stubbs, B.. Prevalence, incidence, and mortality from cardiovascular disease in patients with pooled and specific severe mental illness: a large-scale meta-analysis of 3,211,768 patients and 113,383,368 controls. World Psychiatry, 2017 16(2), 163–180. Doi: 10.1002/wps.20420

Thombs, B. D., Bass, E. B., Ford, D. E., Stewart, K. J., Tsilidis, K. K., Patel, U.,

Fauerbach, J.A., Bush, D.E., & Ziegelstein, R. C. . Prevalence of depression in survivors of acute myocardial infarction. Journal of General Internal Medicine, 2006 21(1), 30-38. Doi: 10.1111/j.1525-1497.2005.00269.x

Tully, P.J., & Baker, R.A. . Depression, Anxiety, and Cardiac Morbidity

Outcomes After Coronary Artery Bypass Surgery: A Contemporary and Practical Review. Journal of Geriatric Cardiology, 2012 9(2), 197-208. Doi: 10.3724/SP.J.1263.2011.12221.

Colquhoun, D.M., Bunker, S.J., Clarke, D.M., Glozier, N, Hare, D.L., Hickie, I.B.,

Tatoulis, J., Thompson, D.R., Tofler, G.H., Wilso, A., & Branagan, M.G . Screening, referral, and treatment for depression in patients with coronary heart disease. Medical Journal of Australia, 2013 20(198), 483-84. Doi: 10.5694/mja13.10153

Carney, R.M., & Freedland, K.E.,. Depression and coronary heart disease.

Nature Reviews Cardiology, 2017 14(3), 145-55. Doi:10.1038/nrcardio.2016.181

Ren Y. Yang H. Browning C. Thomas S. Liu M. Performance of screening tools in detecting major depressive disorder among patients with coronary heart disease: a systematic review. Med. Sci. Monit. 2015; 21: 646-653

Ziegelstein RC, Thombs BD, Coyne JC, de Jonge P. Routine screening for depression in patients with coronary heart disease. Never mind. Journal of the American College of Cardiology. 2009;54(10):886–890.

Huffman JC, Mastromauro CA, Sowden G, Fricchione GL, Healy BC, Januzzi JL. Impact of a depression care management program for hospitalized cardiac patients. Circulation: Cardiovascular Quality and Outcomes. 2011;4(2):198–205.

Davidson KW, Rieckmann N, Clemow L, et al. Enhanced depression care for patients with acute coronary syndrome and persistent depressive symptoms: coronary psychosocial evaluation studies randomized controlled trial. Archives of Internal Medicine. 2010;170(7):600–608.

Katon WJ, Lin EHB, Korff MV, et al. Collaborative care for patients with depression and chronic illnesses. The New England Journal of Medicine. 2010;363(27):2611–2620.

Nishiga, M., Wang, D.W., Han, Y. et al. COVID-19 and cardiovascular disease: from basic mechanisms to clinical perspectives. Nat Rev Cardiol 2020 17, 543–558

North BJ, Sinclair DA. The intersection between aging and cardiovascular disease. Circ Res. 2012;110(8):1097-1108. doi:10.1161/CIRCRESAHA.111.246876

World Health Organisation (WHO) (retrieved 25/8/2020)

Walker E.R., McGee R.E., Druss B.G. Mortality in mental disorders and global disease burden implications: a systematic review and meta-analysis. JAMA Psychiatry. 2015;72(4):334–341.

Serrano C.V., Setani K.T., Sakamoto E., Andrei A.M., Fraguas R. Association between depression and development of coronary artery disease: pathophysiologic and diagnostic implications. Vasc Health Risk Manage. 2011;7:159–164.

Rutledge T., Reis V.A., Linke S.E., Greenberg G.H., Mills P.J. Depression in heart failure: a meta-analytic review of prevalence, intervention effects, and associations with clinical outcomes. J Am Coll Cardiol. 2006;48:1527–1537.

Hansen MC, Flores, DV, Coverdale J, Burnett,J. J Elder Abuse Negl. 2016 Jan-Feb; 28(1): 41–56.

Stamos E, Papaioannou, C, Räihä I, Kivelä Sirkka-Liisa Self-neglect of the elderly. An overview .European Journal of General Practice Volume 2012 18

Riba M Wulsin L Rubenfire M. Ravindranath D Hoboken, Psychiatry and Heart Disease: The Mind, Brain, and Heart Wiley-Blackwell; NJ: 2011.

American Psychiatric Association . 4th ed. American Psychiatric Association; Washington, DC: 1994. Diagnostic and Statistical Manual of Mental Disorders

Brooks S.K., Webster R.K., Smith L.E., Woodland L., Wessely S., Greenberg N. The psychological impact of quarantine and how to reduce it: rapid review of the evidence. The Lancet. 2020;395:10227.

Mukhtar S. Pakistanis’ Mental Health during the COVID-19. Asian J Psychiatry. 2020 doi: 10.1016/j.ajp.2020.102127.

Mukhtar S. Mental wellbeing of nursing staff during the COVID-19 outbreak: a cultural perspective. J Emergency Nurs. 2020 doi: 10.1016/j.jen.2020.04.003.

Mukhtar S. Preparedness and proactive infection control measures of Pakistan during COVID-19 pandemic outbreak. Res Soc Administr Pharmacy. 2020 doi: 10.1016/j.sapharm.2020.04.011.

Mukhtar S. Mental Health and psychosocial aspects of coronavirus outbreak in Pakistan: psychological intervention for public mental health crisis. Asian J Psychiatry. 2020 doi: 10.1016/j.ajp.2020.102069.

Mukhtar S., Mukhtar S. Mental health and psychological distress in people with diabetes during COVID-19. Metabolism. 2020 doi: 10.1016/j.metabol.2020.154248.

Mukhtar S. Mental health and emotional impact of COVID-19: applying Health Belief Model for medical staff to general public of Pakistan. Brain Behavior & Immunity. 2020 doi: 10.1016/j.bbi.2020.04.012.

Erhardt, L. (2009). Cigarette smoking: An undertreated risk factor for cardiovascular disease. Atherosclerosis, 205(1), 23-32.Doi: 10.1016/j.atherosclerosis.2009.01.007 10.

Freiberg, M.S., & Kraemer, K.L. Focus on the Heart: Alcohol Consumption, HIV Infection, and Cardiovascular Disease. Alcohol Research & Health, 2010. 33(3), 237-46. Retrieved from:

Booth, F.W., Roberts, C.K., Matthew, J. & Laye, M.J.,). Lack of exercise is a major cause of chronic diseases. Comprehensive Physiology 2012 2(2),1143–1211. doi:10.1002/cphy.c110025.

Sanhueza, C., Ryan, L., & Foxcroft, D.R. Diet and the risk of unipolar depression in adults: systematic review of cohort studies. Journal of Human Nutrition and Dietetics, 2013 26(1), 56-70. Doi: 10.1111/j.1365-277X.2012.01283.x

Licht, C. M. M., de Geus, E. J. C., & Penninx, B. W. J. H.). Dysregulation of the Autonomic Nervous System Predicts the Development of the Metabolic Syndrome. The Journal of Clinical Endocrinology & Metabolism, 2013 98(6), 2484-93. Doi: 10.1210/jc.2012-3104.

Kop WJ, Gottdiener JS. The role of immune system parameters in the relationship between depression and coronary artery disease. Psychosom Med. 2005; 67 Suppl 1: S37-41.

Theoharides TC, Weinkauf C, Conti P. Brain cytokines and neuropsychiatric disorders. J Clin Psychopharmacol. 2004; 24: 577-581.

Stetler, C., & Miller, G.E.,). Depression and hypothalamic-pituitary-adrenal activation: a quantitative summary of four decades of research. Psychosomatic Medicine 2011 73(2), 114-26. Doi:10.1097/PSY.0b013e31820ad12b

Serretti A, Kato M, De Ronchi D, Kinoshita T. Meta-analysis of serotonin transporter gene promoter polymorphism (5-HTTLPR) association with selective serotonin reuptake inhibitor efficacy in depressed patients. Mol Psychiatry. 2007; 12: 247-257.

Dietricha EA, Kircha GA , Maroteaux L.& Monassier L. Cardiovascular remodeling and the peripheral serotonergic system Archives of Cardiovascular Diseases Volume 110, 2017, Issue 1, , Pages 51-59

Mottillo, S., Filion, K.B., Genest, J., Joseph, L., Pilote, L., Poirier, P., Rinfret, S., Schiffrin, E.L., & Eisenberg, M.J., . The metabolic syndrome and cardiovascular risk a systematic review and meta-analysis. Journal of the American College of Cardiology 2010 56 (14), 1113-32. Doi: 10.1016/j.jacc.2010.05.034

Vogelzangs, N., Beekman, A.t.f., Boelhouwer, I.G., Bandinelli, S., Milaneschi, Y.,Ferrucci, L., & Penninx, B.W.J.H.,. Metabolic depression: a chronic depressive subtype? Findings from the InCHIANTI study of older persons. Journal of Clinical Psychiatry. 2011, 72(5), 598-604. Doi:10.4088/JCP.10m06559

Reaven, G. M. The insulin resistance syndrome. Current Atherosclerosis Reports 2003 5(5), 364-71. Doi:10.1007/s11883-003-0007-0

Pan, A., Ye, X., Franco, O. H., Li, H., Yu, Z., Zou, S., Zhang, Z., Jiao, S., & Lin, X. Insulin resistance and depressive symptoms in middle-aged and elderly Chinese: Findings from the Nutrition and Health of Aging Population in China Study. Journal of Affective Disorders 2008 109(1-2), 75-82. doi:10.1016/j.jad.2007.11.002

Khandaker, G.M., Zuber, V., Rees, J.M.B., Carvalho, L., Mason, A.M., Foley, C.N., Gkatzionis, A., Jones, P.B., & Burgess, S. Shared mechanisms between coronary heart disease and depression: findings from a large UK general population-based cohort. Molecular Psychiatry 2019.. Doi:10.1038/s41380-019-0395-3.

Le Mellédo J-M, Mahil ,N., & Baker,G.B.,. Nitric oxide: A key player in the relation between cardiovascular disease and major depressive disorder? Journal of Psychiatry and Neuroscience, 2004 29(6), 414-16. Retrieved from

Lerman, A.. Endothelial Function: Cardiac Events. Circulation, 2005 111(3), 363-68. Doi:10.1161/01.cir.0000153339.27064.14

Oluwabunmi O Himmelfarb D Commodore-Mensah, Y Improving Medication Adherence in Cardiovascular Disease Prevention: What's New?, The Journal of Cardiovascular Nursing: 2020 - Volume 35 - Issue 1 - p 6-10 doi: 10.1097/JCN.0000000000000645

Mavrides, N., & Nemeroff, C. . Treatment of depression in cardiovascular disease. Depression and Anxiety 2013, 30(4), 328-41. Doi:10.1002/da.22051

Pina, I.L., Di Palo, K.E., Ventura, H.O. (2018). Psychopharmacology and cardiovascular Disease. Journal of the American College of Cardiology, 71(20), 2346–59. Doi: 10.1016/j.jacc.2018.03.458

Wang, J. T., Hoffman, B., & Blumenthal, J. A. Management of depression in patients with coronary heart disease: association, mechanisms, and treatment implications for depressed cardiac patients. Expert Opinion on Pharmacotherapy, 2010, 12(1), 85-98. Doi:10.1517/14656566.2010.513701

Elderon, L., & Whooley, M. A.. Depression and Cardiovascular Disease. Progress in Cardiovascular Diseases, 2013 55(6), 511-23. Doi:10.1016/j.pcad.2013.03.010

Lespérance, F., Frasure-Smith, N., Koszycki, D., Laliberté, M.-A., van Zyl, L. T., Baker, B., … for the CREATE Investigators. Effects of Citalopram and Interpersonal Psychotherapy on Depression in Patients with Coronary Artery Disease. The Canadian Cardiac Randomized Evaluation of Antidepressant and Psychotherapy Efficacy (CREATE) Trial. Journal of the American Medical Association. 2007, 297(4), 367-79. Doi:10.1001/jama.297.4.367

Sipe, W. E. B., & Eisendrath, S. J. (2012). Mindfulness-Based Cognitive Therapy: Theory and Practice. The Canadian Journal of Psychiatry, 57(2), 63-69. Doi:10.1177/070674371205700202

O’Doherty, V., Carr, A., McGrann, A., O’Neill, J. O., Dinan, S., Graham, I., & Maher, V. A controlled evaluation of mindfulness-based cognitive therapy for patients with coronary heart disease and depression. Mindfulness, 2015, 6(3), 405–416.

Anderson, L., Oldridge, N., Thompson, D. R., Zwisler, A.-D., Rees, K., Martin, N., & Taylor, R. S. Exercise-Based Cardiac Rehabilitation for Coronary Heart Disease. Journal of the American College of Cardiology, 2016 67(1), 1-12. Doi: 10.1016/j.jacc.2015.10.044

Davidson, K. W., Bigger, J. T., Burg, M. M., Carney, R. M., Chaplin, W. F., Czajkowski, S., … Ye, S.. Centralized, Stepped, Patient Preference-Based Treatment for Patients with Post–Acute Coronary Syndrome Depression. Journal of American Medical Association Internal Medicine, 2013, 173 (11), 997. Doi:10.1001/jamainternmed.2013.915

Parswani, M.J., Sharma, M.P., Iyengar, S. S.. Mindfulness-based stress reduction program in coronary heart disease: A randomized control trial. International Journal of Yoga 2013, 6(2), 111-7. Doi: 10.4103/0973-6131.113405

Nystoriak, M. A., & Bhatnagar, A. Cardiovascular Effects and Benefits of Exercise. Frontiers in cardiovascular medicine 2018, 5, 135.

Blumenthal, J. A., Sherwood, A., Babyak, M. A., Watkins, L. L., Smith, P. J., Hoffman, B. M., … Hinderliter, A. L. (2012). Exercise and Pharmacological Treatment of Depressive Symptoms in Patients with Coronary Heart Disease. Journal of the American College of Cardiology, 60(12), 1053-63. Doi:10.1016/j.jacc.2012.04.040

Freedland, K. E., Carney, R. M., Rich, M. W., Steinmeyer, B. C., & Rubin, E. H. Cognitive Behavior Therapy for Depression and Self-Care in Heart Failure Patients. Journal of American Medical Association Internal Medicine, 2015 175(11), 1773. doi:10.1001/jamainternmed.2015.5220

Freedland, K.E., Skala, J.A, Carney, R.M., Rubin, E.H., Lustman, P.J., Davila-Roman, V.G., Steinmeyer, B.C., Hogue, C.W. Treatment of depression after coronary artery bypass surgery: a randomized controlled trial. Archives of General Psychiatry, 2009 66(4),387-96. Doi:10.1001/archgenpsychiatry.2009.7

Farah, W. H., Alsawas, M., Mainou, M., Alahdab, F., Farah, M. H., Ahmed, A. T Mohamed, E.S., Almasri, J., Gionfriddo, M.R., Castaneda-Guarderas, A., Mohammed, K., Wang, Z., Asi, N., Sawchuk, C.N.,Williams, M.D., Prokop, L.P., Murad, M.H., & LeBlanc, A.). Non-pharmacological treatment of depression: A systematic review and evidence map. Evidence Based Medicine, 2016 21(6), 214-221. Doi: 10.1136/ebmed-2016-110522

Cote F, Fligny C, Fromes Y, Mallet J, Vodjdani G. Recent advances in understanding serotonin regulation of cardiovascular function. Trends Mol Med. 2004; 10: 232-238.

Li, M., D’Arcy, C., & Meng, X. . Maltreatment in childhood substantially increases the risk of adult depression and anxiety in prospective cohort studies: systematic review, meta-analysis, and proportional attributable fractions. Psychological Medicine, 2015 46(4), 717-30. Doi: 10.1017/S0033291715002743

Su, S., Jimenez, M. P., Roberts, C. T. F., & Loucks, E. B. The Role of Adverse Childhood Experiences in Cardiovascular Disease Risk: A Review with Emphasis on Plausible Mechanisms. Current Cardiology Reports, 2015 17(10). Doi:10.1007/s11886-015

Jokela, M., Pulkki-Raback, L., Elovainio, M., & Kivimäki, M. (). Personality

traits as risk factors for stroke and coronary heart disease mortality: pooled analysis of three cohort studies. Journal of Behavioral Medicine, 2013, 37(5), 881-89. Doi: 10.1007/s10865-013-9548-z

Klein, D. N., Kotov, R., & Bufferd, S. J.. Personality and Depression: Explanatory Models and Review of the Evidence. Annual Review of Clinical Psychology, 2011 7(1), 269–295. Doi:10.1146/annurev-clinpsy-032210- 104540

Penninx, B. W. J. H. (2016). Depression and cardiovascular disease: Epidemiological evidence on their linking mechanisms. Neuroscience & Biobehavioral Reviews, 74, 277-86. Doi:10.1016/j.neubiorev.2016.07.003

Glassman AH, O'Connor CM, Califf RM, et al for the Sertraline Antidepressant Heart Attack Randomized Trial (SADHART) Group. Sertraline Treatment of Major Depression in Patients With Acute MI or Unstable Angina. JAMA 2002;288:701-09. Hare, D. L., Toukhsati, S. R., Johansson, P., & Jaarsma, T. 2013. Depression and cardiovascular disease: a clinical review. European Heart Journal, 35(21), 1365-72. Doi:10.1093/eurheartj/eht462.

Kim, J.-M., Stewart, R., Lee, Y.-S., Lee, H.-J., Kim, M. C., Kim, J.-W., … Yoon, J.-S.. Effect of Escitalopram vs Placebo Treatment for Depression on Long-term Cardiac Outcomes in Patients with Acute Coronary Syndrome. Journal of American Medical Association, 2018 320(4), 350-57. Doi:10.1001/jama.2018.9422

Cipriani, A., Brambilla, P., Furukawa, T., Geddes, J., Gregis, M., Hotopf, M., Malvini, L., & Barbui, C.). Fluoxetine versus other types of pharmacotherapy for depression. The Cochrane database of systematic reviews, 2005 (4), CD004185.

Palmer S.C. (2013) Hospital Anxiety Depression Scale. In: Gellman M.D., Turner J.R. (eds) Encyclopedia of Behavioral Medicine. Springer, New York, NY.

Borowsky SJ, Rubenstein LV, Meredith LS, Camp P, Jackson-Triche M, Wells KB. Who is at risk of nondetection of mental health problems in primary care? J Gen Intern Med 2000 15, pp. 381-388

Iris, M., Ridings, J. & Conrad, K. The development of a conceptual model for understanding elder self-neglect. The Gerontologist 2010 50, 303-315.

Player MS, Peterson LE. Anxiety disorders, hypertension, and cardiovascular risk: a review. Int J Psychiatry Med 2011;41(4):365–77.

Kulshreshtha A, Vaccarino V, Judd SE, Howard VJ, McClellan WM, Muntner P, Hong Y, Safford MM, Goyal A, Cushman M. Life's Simple 7 and risk of incident stroke: the reasons for geographic and racial differences in stroke study. Stroke. 2013; 44:1909–1914.

Folsom AR, Shah AM, Lutsey PL, Roetker NS, Alonso A, Avery CL, Miedema MD, Konety S, Chang PP, Solomon SD. American Heart Association's Life's Simple 7: avoiding heart failure and preserving cardiac structure and function. Am J Med. 2015; 128(970–976):e972.

Olson NC, Cushman M, Judd SE, McClure LA, Lakoski SG, Folsom AR, Safford MM, Zakai NA. American Heart Association's Life's Simple 7 and risk of venous thromboembolism: the Reasons for Geographic and Racial Differences in Stroke (REGARDS) study. J Am Heart Assoc. 2015; 4:e001494. DOI: 10.1161/JAHA.114.001494.

Rebholz CM, Anderson CA, Grams ME, Bazzano LA, Crews DC, Chang AR, Coresh J, Appel LJ. Relationship of the American Heart Association's Impact Goals (Life's Simple 7) with risk of chronic kidney disease: results from the Atherosclerosis Risk in Communities (ARIC) cohort study. J Am Heart Assoc. 2016; 5:e003192. DOI: 10.1161/JAHA.116.003192.

Riegel B, Moser DK, Buck HG, Dickson VV, Dunbar SB, Lee CS, Lennie TA, Lindenfeld J, Mitchell JE, Treat-Jacobson DJ, Webber DE. Self-Care for the Prevention and Management of Cardiovascular Disease and Stroke: A Scientific Statement for Healthcare Professionals From the American Heart Association J Am Heart Assoc 2017 Aug 31;6(9)e006997.